NAME AND POSITION
Vasileios S Skouras, MD, PhD, FCCP
Pulmonologist, Dept of Pulmonary Medicine, 401 General Army Hospital of Athens

GRADUATE AND/OR MEDICAL EDUCATION:

M.D. (2000 – School of Medicine, “Aristotle” University of Thessaloniki)
PhD (2012 – School of Medicine, University of Thessaly)

POSTDOCTORAL TRAINING:

• 2008 – Research in Pleural Diseases – Division of Allergy, Pulmonary and Critical Care Medicine, School of Medicine, Vanderbilt University, Nashville, TN, USA
• 2012-2013 – Training in Thoracic Oncology – Division of Pulmonary, Critical Care, Allergy and Sleep Medicine Thoracic Oncology Lab, Medical University of South Carolina, Charleston, SC, USA

MAJOR ACADEMIC APPOINTMENTS:

• 2009 – 2014: Scientific Associate, First Department of Critical Care & Pulmonary Medicine, GP Livanos and M Simou Laboratories, Medical School of Athens University, “Evangelismos” Hospital, Athens
• 2014 – 2015: Member of Educational Committee of Master in Thoracic Oncology 3rd University Department of Internal Medicine National & Kapodistrian University of Athens (Greece)
• 2008: Research Fellow, Division of Allergy, Pulmonary and Critical Care Medicine, School of Medicine, Vanderbilt University, Nashville, TN, USA

MAJOR HOSPITAL APPOINTMENTS:

• 2010 – 2012 & 2013 – present: Attending Physician, Dept of Pulmonary Medicine, 401 General Army Hospital of Athens (Greece)
• 2016 – present: Associate Pulmonologist, 1st Dept of Pulmonary Medicine, HYGEIA Hospital (Greece)

OTHER MAJOR PROFESSIONAL POSITIONS AND MAJOR VISITING APPOINTMENTS:

• 2012-2013: Visiting Professor in Thoracic Oncology, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine Thoracic Oncology Lab, Medical University of South Carolina, Charleston, SC, USA
• 2008: Research Fellow, Division of Allergy, Pulmonary and Critical Care Medicine, School of Medicine, Vanderbilt University, Nashville, TN, USA

MAJOR HONORS AND AWARDS:

• 2011: Training Award, 1-year training in Thoracic Oncology, Hellenic Thoracic Society
• 2007: Research Award, “Indicators of poor prognosis in parapneumonic effusions: the role of innate immunity and coagulation/fibrinolysis activity”, Hellenic Thoracic Society

GRADUATE TEACHING EXPERIENCE AND RESPONSIBILITIES:

• Invited lectures to national conferences, post-graduate courses and training courses in pulmonary medicine
• Member of Educational Committee of Master in Thoracic Oncology
RESEARCH FUNDING DURING THE LAST FIVE YEARS
• 2011 – Thorax Foundation (Athens, Greece): partial financial support for the study “IL-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence”

LIST OF FIVE OF THE MOST IMPORTANT RECENT PUBLICATIONS

• Skouras VS, Kalomenidis I. Effusions caused by drugs. In: Textbook of pleural diseases, 3rd edition. Editors: Light RW, Lee YCG (under publication)
• Skouras VS, Magkouta S, Psallidas I, Tsilioni I, Maragozidis P, Gourgoulianis KI, Kalomenidis I. Interleukin-27 improves the ability of adenosine deaminase to rule-out tuberculous pleural effusion regardless of pleural tuberculosis prevalence. Infect Dis (Lond), 2015;47(7):477-83
• Skouras VS, Pastis NJ, Polychronopoulos V, Silvestri GA. Mediastinal staging in lung cancer. The quest for a cost-effective strategy. Pneumon, 2014;27(1):16-31
• Skouras VS, Tanner NT, Silvestri GA. Diagnostic approach to the solitary pulmonary nodule. Semin Respir Crit Care Med, 2013;34(6):762-9
• Skouras V, Boultadakis E, Nikoulis D, Polychronopoulos V, Daniil Z, Kalomenidis I, Gourgoulianis KI. Prognostic value of C-reactive protein in parapneumonic effusions. Respirology, 2012;17(2):308-14

LIST OF FIVE MOST IMPORTANT PUBLICATIONS OF THE CAREER

• Skouras VS, Kalomenidis I. Effusions caused by drugs. In: Textbook of pleural diseases, 3rd edition. Editors: Light RW, Lee YCG (under publication)
• Skouras VS, Magkouta S, Psallidas I, Tsilioni I, Maragozidis P, Gourgoulianis KI, Kalomenidis I. Interleukin-27 improves the ability of adenosine deaminase to rule-out tuberculous pleural effusion regardless of pleural tuberculosis prevalence. Infect Dis (Lond), 2015;47(7):477-83
• Skouras VS, Tanner NT, Silvestri GA. Diagnostic approach to the solitary pulmonary nodule. Semin Respir Crit Care Med, 2013;34(6):762-9
• Skouras V, Boultadakis E, Nikoulis D, Polychronopoulos V, Daniil Z, Kalomenidis I, Gourgoulianis KI. Prognostic value of C-reactive protein in parapneumonic effusions. Respirology, 2012;17(2):308-14
• Skouras V, Awdankiewicz A, Light RW. What size parapneumonic effusions should be sampled? Thorax, 2010;65(1):91